Back to Journals » Cancer Management and Research » Volume 4

Update on the management of invasive bladder cancer 2012

Authors Goethuys, Van Poppel H

Received 14 February 2012

Accepted for publication 31 May 2012

Published 18 July 2012 Volume 2012:4 Pages 177—182

DOI https://doi.org/10.2147/CMAR.S30850

Review by Single-blind

Peer reviewer comments 5


Hans Goethuys,1 Hein Van Poppel1,2

1Department of Urology, Ziekenhuis Oost-Limburg, Genk, Belgium; 2Department of Urology, University Hospital Leuven, Leuven, Belgium

Abstract: Muscle-invasive bladder cancer is a deadly disease for which a number of new approaches have become available to improve prognosis. A recent review emphasized the importance of timely indication of surgery and highlighted current views regarding the adequate extent of the surgery and the importance of lymph node dissection. Furthermore, treatment using neoadjuvant and adjuvant systemic chemotherapy has become more prominent, while cystectomy and diversion should be conducted only in experienced centers. Optimal methods of urinary diversion and the use of robot-assisted laparoscopic cystectomy require further study.

Keywords: bladder cancer, surgery, chemotherapy, urinary diversion

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]